Farmas USA

bueno, a juzgar por el comportamiento del DAX, IBEX .... ni un rebotillo vamos a tener hoy :( ...

Es verdad, estoy tan enganchado al FarmasUsa que se me olvida que hay otros hilos. :-D

Si, es mejor poner lo de THLD en su hilo.

Cierto, a veces soy monohilárico. ;-P

El mercado de los estudios toxicológicos in vitro

The global in-vitro toxicology testing market is estimated to reach $17,227 million by 2018 at a CAGR of 13.5% during the forecast period (2013–2018). The market will witness a double-digit growth attributed to the increasing acceptance of in vitro methods over in vivo ones.

However, reluctance of regulatory authorities to consider alternate methods for proving safety and efficacy will obstruct market growth. Of all the industries, pharmaceutical industry had the largest market share in 2013, whereas cosmetic industry will be the fastest-growing market in the coming five years. The rising pressure to reduce the drug attrition rates to curb the drug development costs, and the timeline in the pharmaceutical industry has led to the increased adoption of in vitro methods in the detection of potential toxic effects much earlier in the development path. The pharmaceutical industry has been witnessing a tremendous growth as a result of government initiatives such as AXLR8 program that was initiated by the European Union. The cosmetic industry will grow the fastest owing to the amendment of European Union’s Cosmetics Directive that has set forth ban on the use of animals in testing for any toxic effects of beauty products...

Cell culture technology is gaining acceptance as the necessary tool to determine toxicity in earlier stages of drug development. With the introduction of 3D models the cell based assays will further observe strong growth...

Habrá que seguir bien las ONVO.

http://www.marketsandmarkets.com/Market-Reports/in-vitro-toxicology-testing-market-209577065.html

ACTC mencionada en el The Times

http://www.thetimes.co.uk/tto/public/eyehealth/article4164125.ece?CMP=OTH-gnws-standard-2014_08_01

Que se te olvidan las HEB!!! que son capaces de curar in-vitro el SARS, el MERS, el HIV y ahora dicen que el Ebola. Si es que nadie les hace caso pero con Ampligen han encontrado la piedra filosofal!! Que gran incomprendida!!

Edito para que nadie se lleve a engaño, hablaba en modo irónico por no decir sarcástico.

http://seekingalpha.com/article/2376595-amarin-starting-to-show-some-modest-vascepa-growth?app=1&uprof=44

AMRN

Edito: REPETIDO